Pharmaceutical companies in the United States by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 44 pharmaceutical companies in the United States ranked by one-year price change, at +395%, ahead of Spyre Therapeutics (+332%) and Oruka Therapeutics (+255%). Figures as of 20 Nov 2026, 05:42 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- Erasca+395%
- Median
- +27.7%
- Combined market value
- AED 13.72T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +395% | AED 18.3B | AED 52.23 | 3.34% up | 395% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +332% | AED 34.1B | AED 358.57 | 3.77% down | 332% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +255% | AED 24.3B | AED 358.35 | 1.91% up | 255% up | ||
| 4 | VeradermicsMANE · Health Care | +231% | AED 19.3B | AED 456.85 | 0.38% down | 231% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +168% | AED 14.8B | AED 108.27 | 1.24% up | 168% up | ||
| 6 | TG TherapeuticsTGTX · Health Care | +117% | AED 36B | AED 238.28 | 1.88% down | 117% up | ||
| 7 | Dianthus TherapeuticsDNTH · Health Care | +108% | AED 17.5B | AED 311.56 | 1.01% up | 108% up | ||
| 8 | ViatrisVTRS · Health Care | +99.0% | AED 83.7B | AED 73.01 | 1.97% down | 99% up | ||
| 9 | Amneal PharmaceuticalsAMRX · Health Care | +90.0% | AED 27.4B | AED 78.56 | 2.24% down | 90% up | ||
| 10 | Praxis Precision MedicinesPRAX · Health Care | +86.0% | AED 31.9B | AED 1,141.84 | 1.87% up | 86% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | +85.9% | AED 16.6B | AED 151.21 | 0.48% down | 86% up | ||
| 12 | Royalty PharmaRPRX · Health Care | +78.9% | AED 143B | AED 248.72 | 1.38% down | 79% up | ||
| 13 | Protagonist TherapeuticsPTGX · Health Care | +51.0% | AED 29.7B | AED 455.49 | 2.47% down | 51% up | ||
| 14 | Ligand PharmaceuticalsLGND · Health Care | +50.1% | AED 21.1B | AED 1,053.84 | 3.94% down | 50% up | ||
| 15 | Merck & CoMRK · Health Care | +45.1% | AED 1.2T | AED 487.77 | 3.61% down | 45% up | ||
| 16 | Travere TherapeuticsTVTX · Health Care | +44.7% | AED 17B | AED 177.39 | 3.86% down | 45% up | ||
| 17 | Belite BioBLTE · Health Care | +43.1% | AED 22.5B | AED 554.65 | 3.33% down | 43% up | ||
| 18 | Johnson & JohnsonJNJ · Health Care | +34.3% | AED 2.36T | AED 981.13 | 2.04% down | 34% up | ||
| 19 | Mirum PharmaceuticalsMIRM · Health Care | +33.7% | AED 22.9B | AED 350.78 | 3.27% up | 34% up | ||
| 20 | Eli LillyLLY · Health Care | +32.5% | AED 4.42T | AED 4,962.26 | 2.29% down | 33% up | ||
| 21 | Bristol-Myers SquibbBMY · Health Care | +29.6% | AED 438B | AED 214.27 | 2.05% down | 30% up | ||
| 22 | Regeneron PharmaceuticalsREGN · Health Care | +28.3% | AED 350.8B | AED 3,391.15 | 2.35% down | 28% up | ||
| 23 | Vertex PharmaceuticalsVRTX · Health Care | +27.0% | AED 484.8B | AED 1,912.23 | 2.94% down | 27% up | ||
| 24 | Elanco Animal HealthELAN · Health Care | +25.7% | AED 48.3B | AED 96.56 | 1.54% down | 26% up | ||
| 25 | AbbVieABBV · Health Care | +24.7% | AED 1.84T | AED 1,041.36 | 0.86% down | 25% up | ||
| 26 | United TherapeuticsUTHR · Health Care | +21.6% | AED 87.5B | AED 2,053.41 | 3.16% down | 22% up | ||
| 27 | BridgeBio PharmaBBIO · Health Care | +20.7% | AED 55.9B | AED 287.13 | 0.22% up | 21% up | ||
| 28 | Rhythm PharmaceuticalsRYTM · Health Care | +18.3% | AED 29.7B | AED 428.97 | 1.88% down | 18% up | ||
| 29 | BioMarin PharmaceuticalBMRN · Health Care | +17.1% | AED 43.7B | AED 225.58 | 0.02% down | 17% up | ||
| 30 | PfizerPFE · Health Care | +15.0% | AED 576.5B | AED 101.15 | 1.85% down | 15% up | ||
| 31 | Arrowhead PharmaceuticalsARWR · Health Care | +13.2% | AED 22.7B | AED 160.31 | 1.25% up | 13% up | ||
| 32 | Axsome TherapeuticsAXSM · Health Care | -6.50% | AED 26.2B | AED 498.31 | 1.25% up | 6% down | ||
| 33 | Corcept TherapeuticsCORT · Health Care | -9.67% | AED 26.1B | AED 238.65 | 4.15% down | 10% down | ||
| 34 | Abbott LaboratoriesABT · Health Care | -15.7% | AED 660.7B | AED 381.48 | 0.58% down | 16% down | ||
| 35 | CytokineticsCYTK · Health Care | -19.2% | AED 26.3B | AED 189.00 | 0.27% up | 19% down | ||
| 36 | Cogent BiosciencesCOGT · Health Care | -19.9% | AED 17.7B | AED 101.88 | 0.25% down | 20% down | ||
| 37 | PTC TherapeuticsPTCT · Health Care | -21.2% | AED 17.9B | AED 214.21 | 3.16% down | 21% down | ||
| 38 | ZoetisZTS · Health Care | -26.2% | AED 120.6B | AED 296.72 | 5.59% down | 26% down | ||
| 39 | Madrigal PharmaceuticalsMDGL · Health Care | -26.6% | AED 33.8B | AED 1,457.11 | 0.34% down | 27% down | ||
| 40 | Summit TherapeuticsSMMT · Health Care | -36.2% | AED 31B | AED 38.82 | 0.67% up | 36% down | ||
| 41 | InsmedINSM · Health Care | -40.0% | AED 116.4B | AED 530.56 | 20.58% up | 40% down | ||
| 42 | Legend BiotechLEGN · Health Care | -41.0% | AED 11.5B | AED 59.13 | 0.92% down | 41% down | ||
| 43 | Ionis PharmaceuticalsIONS · Health Care | -62.5% | AED 16.6B | AED 99.97 | 0.62% down | 63% down | ||
| 44 | Alnylam PharmaceuticalsALNY · Health Care | -66.5% | AED 72.7B | AED 542.90 | 1.06% down | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6727 AED).
Questions and answers
Which pharmaceutical companies in the United States rank first by one-year price change?
Erasca (+395%), Spyre Therapeutics (+332%) and Oruka Therapeutics (+255%) are the top three of the 44 pharmaceutical companies in the United States ranked by one-year price change as of 20 Nov 2026, 05:42 UTC.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by one-year price change.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by one-year price change have a combined market value of AED 13.72T as of 20 Nov 2026, 05:42 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceutical companies in the United States by one-year price change”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.